Objective Biotechnology, Inc. — Form D

Objective Biotechnology, Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-26. The offering totals $1.0M, of which $715K was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-11-26
Form: D
Accession: 0002045193-24-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.0M
Amount sold: $715K
Remaining: $285K
Investors: 11
Date of first sale: 2024-11-20
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-530516

Issuer

Name: Objective Biotechnology, Inc.
CIK: 0002045193
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2023
Address: 126 N. THIRD STREET, SUITE 540, MINNEAPOLIS, MN, 55401
Phone: 507-321-9119

Officers, directors & promoters (11)

Name	Role	Location
Andrew Alegria	Director	Minneapolis, MN
Daryl Gohl	Director	Minneapolis, MN
Amey Joshi	Director	Minneapolis, MN
Suhasa Kodandaramaiah	Director	Minneapolis, MN
Daniel Surinach	Director	Minneapolis, MN
Andrew Alegria	Executive Officer	Minneapolis, MN
Daryl Gohl	Executive Officer	Minneapolis, MN
James Grabau	Executive Officer	Minneapolis, MN
Amey Joshi	Executive Officer	Minneapolis, MN
Suhasa Kodandaramaiah	Executive Officer	Minneapolis, MN
Daniel Surinach	Executive Officer	Minneapolis, MN

More